These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30585930)

  • 1. Retinitis Pigmentosa: Review of Current Treatment.
    Wang AL; Knight DK; Vu TT; Mehta MC
    Int Ophthalmol Clin; 2019; 59(1):263-280. PubMed ID: 30585930
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic approaches for retinitis pigmentosa].
    Pach J; Gekeler F
    Klin Monbl Augenheilkd; 2013 May; 230(5):512-8. PubMed ID: 23695848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review.
    Bakthavatchalam M; Lai FHP; Rong SS; Ng DS; Brelen ME
    Surv Ophthalmol; 2018; 63(3):329-339. PubMed ID: 28987613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention.
    Strong S; Liew G; Michaelides M
    Br J Ophthalmol; 2017 Jan; 101(1):31-37. PubMed ID: 27913439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Cystoid Macular Edema in Retinitis Pigmentosa.
    Huckfeldt RM; Comander J
    Semin Ophthalmol; 2017; 32(1):43-51. PubMed ID: 27748628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retinitis pigmentosa: pathogenic progress and therapeutic hopes].
    Sahel JA
    Rev Prat; 2002 Oct; 52(16):1745-7. PubMed ID: 12564163
    [No Abstract]   [Full Text] [Related]  

  • 7. Bimanual Technique for Retinal Tacking of Epiretinal Prosthesis.
    Gregori NZ; Davis JL; Rizzo S
    Retina; 2016 Jan; 36(1):199-202. PubMed ID: 26441271
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients.
    Liu Y; Chen SJ; Li SY; Qu LH; Meng XH; Wang Y; Xu HW; Liang ZQ; Yin ZQ
    Stem Cell Res Ther; 2017 Sep; 8(1):209. PubMed ID: 28962643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RECURRENT CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH RETINITIS PIGMENTOSA TREATED WITH CARBONIC ANHYDRASE INHIBITORS.
    Pomykala M; Rubin P; Rubin JS
    Retin Cases Brief Rep; 2016; 10(3):205-7. PubMed ID: 26510001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracompartmental delivery of CNTF as therapy for Huntington's disease and retinitis pigmentosa.
    Emerich DF; Thanos CG
    Curr Gene Ther; 2006 Feb; 6(1):147-59. PubMed ID: 16475952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciliary neurotrophic factor therapy for inherited retinal diseases: pros and cons.
    Bok D
    Retina; 2005 Dec; 25(8 Suppl):S27-S28. PubMed ID: 16374322
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Giuffre G
    Am J Ophthalmol; 2006 Oct; 142(4):707; author reply 707-8. PubMed ID: 17011883
    [No Abstract]   [Full Text] [Related]  

  • 13. Vision Restoration in Outer Retinal Degenerations: Current Approaches and Future Directions.
    Saraf SS; Olmos de Koo LC
    Int Ophthalmol Clin; 2019; 59(1):59-69. PubMed ID: 30585918
    [No Abstract]   [Full Text] [Related]  

  • 14. Personalized therapeutic strategies for patients with retinitis pigmentosa.
    Zheng A; Li Y; Tsang SH
    Expert Opin Biol Ther; 2015 Mar; 15(3):391-402. PubMed ID: 25613576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances of stem cell therapy for retinitis pigmentosa.
    He Y; Zhang Y; Liu X; Ghazaryan E; Li Y; Xie J; Su G
    Int J Mol Sci; 2014 Aug; 15(8):14456-74. PubMed ID: 25141102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year Follow-Up of a Subretinal Silicon Prosthesis for Retinitis Pigmentosa.
    Khan MA; Ho AC; Haller JA
    Ophthalmology; 2015 Oct; 122(10):2114. PubMed ID: 26398053
    [No Abstract]   [Full Text] [Related]  

  • 17. Encapsulated cell technology could prevent blindness.
    Burnham CM
    Drug Discov Today; 2003 Feb; 8(4):146-7. PubMed ID: 12581701
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
    Liew G; Moore AT; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A discussion about key issues in retinal prosthesis].
    Peng C; Xia L; Wang X; Zheng E
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):671-5. PubMed ID: 19634695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
    Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J
    Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.